172
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

5-HT2A and 5-HT3 receptors contribute to the exacerbation of targeted and non-targeted effects of ionizing radiation-induced cell death in human colon carcinoma cells

, , &
Pages 482-490 | Received 17 Jul 2019, Accepted 18 Nov 2019, Published online: 08 Jan 2020
 

Abstract

Purpose: Serotonin (5-HT) is implicated in the underlying mechanisms which mediate cell death following ionizing radiation exposure, however, effects appear to be cell type-dependent. We sought to further characterize the role of 5-HT and 5-HT receptors (5-HTRs) in the exacerbation of cell death following ionizing radiation exposure in human colon carcinoma cells.

Materials and methods: We examined the clonogenic survival of colon carcinoma HCT116 cells treated with 5-HT and the selective 5-HTR antagonists ketanserin (5-HT2A) and ondansetron (5-HT3), following exposure to direct ionizing radiation and irradiated cell-conditioned medium (ICCM). The relative expression of these target receptors was measured using western blotting.

Results: Western blotting results revealed that relative protein levels of the 5-HT2A and 5-HT3 receptors were similar. 5-HT concentration-dependent increases in cell death that occurred following direct ionizing radiation exposure were abolished by both 5-HTR antagonists. Death of nonirradiated cells recipient of ICCM was increased in a concentration-dependent manner by 5-HT when present during donor cell irradiation. Both 5-HTR antagonists completely abolished the increases in bystander-induced cell death generated by 5-HT. Finally, we show that exposure of cells to 5-HT prior to receipt of ICCM can also dictate the degree of bystander-induced cell death.

Conclusions: Our findings demonstrate a definitive role for 5-HT in the exacerbation of cell death following ionizing radiation exposure in colon carcinoma cells and highlight 5-HTRs as potential markers for predicting cellular radiosensitivity.

Acknowledgements

Thank you to the McMaster Honors Biology and Pharmacology Program for the support throughout the preparation of this work. Thank you to Sarah Cash for aiding with the preparation of figures.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Canadian Research Chairs Program [grant number 950-221284]; National Chronic Fatigue and Immune Dysfunction Syndrome Foundation Inc.; Natural Sciences and Engineering Research Council Collaborative Research and Development Grant [grant number RGPIN293153-12]; CANDU Owners Group [grant number CRDPJ484381-15]; Bruce Power; and the Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award program.

Notes on contributors

Jacob J. Curtis

Jacob J. Curtis, Hons BHSc (Pharmacology), is a former laboratory research assistant at the Department of Biology, McMaster University, Hamilton, ON, Canada and is currently pursuing a Doctor of Pharmacy at the Leslie Dan Faculty of Pharmacy at the University of Toronto, ON, Canada.

Nguyen T. K. Vo

Dr. Nguyen T. K. Vo, PhD, is a Postdoctoral Fellow at the Department of Biology, McMaster University, Hamilton, ON, Canada.

Colin B. Seymour

Dr. Colin B. Seymour, PhD, is a Professor at the Department of Biology, McMaster University, Hamilton, ON, Canada.

Carmel E. Mothersill

Dr. Carmel E. Mothersill, PhD, is Professor at the Department of Biology, McMaster University, Hamilton, ON, Canada.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.